Numinus First Canadian Public Company to Complete Legal Harvest of Psilocybe Mushrooms Oct 22 • 7 min read Numinus Wellness Inc. has harvested the first legal flush of Psilocybe mushrooms in Canada by a public company under its Health Canada-issued Controlled Drugs and Substances Dealer’s Licence.
Pharmather Files for FDA Orphan Drug Designation for Ketamine in Parkinson’s Disease Oct 21 • 6 min read Pharmather Inc. announced it has filed an application with the U.S. FDA to receive Orphan Drug Designation for ketamine.
Revive Therapeutics Signs Supply Agreement With Havn Life Sciences for Psychedelic Compounds Oct 20 • 6 min read Revive Therapeutics Ltd. announced it has signed an agreement with Havn Life Sciences Inc. to source naturally-derived psychedelic compounds for use in future investigational new drug.
Cybin and Clarmin Announce Closing of CDN$45 Million Oversubscribed Private Placement and Provide Update on RTO Oct 19 • 9 min read Cybin and Clarmin announced the closing of a private placement offering of an aggregate of 60M subscription receipts at a price of CDN$0.75 per subscription receipt for proceeds of CDN$45M.
MindMed Files Preliminary Prospectus In Connection With Bought Deal Equity Financing Oct 19 • 5 min read Mind Medicine (MindMed) Inc. announced that it has filed a preliminary short form prospectus with the securities commissions or similar authorities in each province of Canada, other than Québec.